Krause und Pachernegg
Verlag für Medizin und Wirtschaft
Artikel   Bilder   Volltext

Mobile Version
A-  |   A  |   A+
Werbung
 
Dia-Präsentation von SERVIER
EUROPA-Studie (Perindopril) (60 Abbildungen)
Übersicht
Gesamtpräsentation zum Download (rechte Maustaste und "Ziel speichern unter..." klicken)


Zum ersten Bild Abb. 30: EUROPA-Studie - Patientenrekrutierung Abb. 31: EUROPA-Studie - Zentren Abb. 32: EUROPA-Studie - Ausschlußkriterien Aktuelles Bild - Abb. 33: EUROPA-Studie - Charakteristika Abb. 34: EUROPA-Studie - Anamnese Abb. 35: EUROPA-Studie - Risikofaktoren Abb. 36: EUROPA-Studie - Medikation Zum letzten Bild
Abbildung 33: EUROPA-Studie - Charakteristika
The analysis of the baseline characteristics of patients recruited into the study showed that: Patients were at least 18 years without clinical evidence of heart failure and with evidence of coronary artery disease. In average they were 60 years old which is not old for coronary artery disease. They were largely men: 86%, weight: 81 + 12, heart rate: 68 + 10 and they had normal blood pressure. Importantly, there were no differences between these two groups, perindpril and placebo, almost identically matched.
 
EUROPA-Studie - Charakteristika
Vorheriges Bild Nächstes Bild   


Abbildung 33: EUROPA-Studie - Charakteristika
The analysis of the baseline characteristics of patients recruited into the study showed that: Patients were at least 18 years without clinical evidence of heart failure and with evidence of coronary artery disease. In average they were 60 years old which is not old for coronary artery disease. They were largely men: 86%, weight: 81 + 12, heart rate: 68 + 10 and they had normal blood pressure. Importantly, there were no differences between these two groups, perindpril and placebo, almost identically matched.
 
copyright © 2003–2017 Krause & Pachernegg GmbH | Sitemap | Impressum
 
Werbung